Literature DB >> 7704450

Ochratoxin A in human serum samples collected in southern Italy from healthy individuals and individuals suffering from different kidney disorders.

A Breitholtz-Emanuelsson1, F Minervini, K Hult, A Visconti.   

Abstract

Ochratoxin A was determined in human serum samples, collected in the south of Italy in November 1992, using ion-pair liquid chromatography and fluorescence detection. The samples were collected from healthy people (65 subjects) as well as from people with different kidney disorders. Five different kinds of kidney disorders were represented: transplanted subjects (13), chronic glomerulonephritis (8), renal calculus or cyst (6), chronic renal failure (13), and subjects treated by dialysis (28). The mean and median concentrations of ochratoxin A in the healthy group was 0.53 and 0.44 ng/ml serum, respectively. The highest mean concentration was found in the group of patients treated by dialysis, 1.4 ng/ml serum. A higher incidence of samples containing > 0.44 ng ochratoxin A/ml serum was found in the dialysis group, compared to the other groups. Comparing the mean concentrations by Student's t-test, a significant difference was found between the mean concentrations of the healthy group and of the group of patients treated by dialysis (P < 0.01). No other significant differences were found when comparing the groups two at a time.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7704450

Source DB:  PubMed          Journal:  Nat Toxins        ISSN: 1056-9014


  12 in total

1.  Rapid method for the determination of ochratoxin A in urine by immunoaffinity column clean-up and high-performance liquid chromatography.

Authors:  M Pascale; A Visconti
Journal:  Mycopathologia       Date:  2001       Impact factor: 2.574

2.  Implications of fungal infections and mycotoxins in camel diseases in Saudi Arabia.

Authors:  Fardos M Bokhari
Journal:  Saudi J Biol Sci       Date:  2010-01       Impact factor: 4.219

3.  Preliminary results on Ochratoxin A concentrations in blood of patients with various kidney diseases in Germany.

Authors:  G Schwerdt; C Schuster; S Silbernagl; M Gareis; M Gekle
Journal:  Mycotoxin Res       Date:  2001-06       Impact factor: 3.833

4.  Ochratoxin A and fumonisins (B1 and B 2) in maize from Balkan nephropathy endemic and non endemic areas of Croatia.

Authors:  Z Jurjevic; M Solfrizzo; B Cvjetkovic; G Avantaggiato; A Visconti
Journal:  Mycotoxin Res       Date:  1999-06       Impact factor: 3.833

5.  Ochratoxin A in human blood serum - retrospective long-term data.

Authors:  Erwin Märtlbauer; Ewald Usleber; Richard Dietrich; Elisabeth Schneider
Journal:  Mycotoxin Res       Date:  2009-09-15       Impact factor: 3.833

6.  The level of ochratoxin a in patients after nephrectomy.

Authors:  J Grajewski; P Jarzemski; M Twaruzek; K Kuzminska; M Trepala
Journal:  Mycotoxin Res       Date:  2007-03       Impact factor: 3.833

7.  Ochratoxin A in porcine blood and in consumed feed samples.

Authors:  K Kotowski; J Grabarkiewicz-Szczesna; A Waskiewicz; M Kostecki; P Golinski
Journal:  Mycotoxin Res       Date:  2000-06       Impact factor: 3.833

Review 8.  Ochratoxin A and human health risk: a review of the evidence.

Authors:  Travis R Bui-Klimke; Felicia Wu
Journal:  Crit Rev Food Sci Nutr       Date:  2015       Impact factor: 11.176

Review 9.  Ochratoxin a in Portugal: a review to assess human exposure.

Authors:  Sofia C Duarte; Angelina Pena; Celeste M Lino
Journal:  Toxins (Basel)       Date:  2010-06-01       Impact factor: 4.546

10.  Mycotoxins' activity at toxic and sub-toxic concentrations: differential cytotoxic and genotoxic effects of single and combined administration of sterigmatocystin, ochratoxin A and citrinin on the hepatocellular cancer cell line Hep3B.

Authors:  Nikolia Anninou; Ekaterini Chatzaki; Fotini Papachristou; Muichail Pitiakoudis; Constantinos Simopoulos
Journal:  Int J Environ Res Public Health       Date:  2014-02-07       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.